Combo Immunotherapy May Change Treatment for Kidney Cancer

Share this content:

A study conducted by the University of Texas Southwestern found a combination therapy of two immunotherapy drugs doubles the response in kidney cancer patients. 

You must be a registered member of Renal and Urology News to post a comment.